Cumberland Pharmaceuticals, Inc. (CPIX) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1152892,
    "name": "Cumberland Pharmaceuticals, Inc.",
    "stock_name": "Cumberland Pharmaceuticals, Inc.",
    "full_name": "Cumberland Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/cumberland-pharmaceuticals-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.35",
    "chg": 0.19,
    "chgp": "8.8%",
    "dir": 1,
    "prev_price": "2.16",
    "mcapval": "49.52",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US2307701092",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "203.99 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cumberland-pharmaceuticals-inc-1152892-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Cumberland Pharmaceuticals, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-cumberland-pharmaceuticals-inc-technically-bullish-or-bearish-3546451",
        "imagepath": "",
        "date": "2025-09-20 19:33:06",
        "description": "As of 20 August 2025, the technical trend for Cumberland Pharmaceuticals, Inc. has changed from mildly bullish to mildly bearish. The weekly MACD and KST are both bearish, while the monthly MACD and KST are bullish, indicating mixed signals across time frames. The daily moving averages are bearish, and the weekly Bollinger Bands are also bearish, contributing to the overall bearish stance. The Dow Theory shows a mildly bearish trend on the weekly chart with no trend on the monthly chart. \n\nIn terms of performance, the stock has outperformed the S&P 500 over the past year with a return of 164.80% compared to the S&P 500's 17.14%, but it has underperformed over the last 3 years and 5 years. Overall, the current technical stance is mildly bearish, reflecting short-term weakness despite strong long-term performance...."
      },
      {
        "title": "Is Cumberland Pharmaceuticals, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-cumberland-pharmaceuticals-inc-overvalued-or-undervalued-3543030",
        "imagepath": "",
        "date": "2025-09-20 18:08:46",
        "description": "As of 2 August 2016, the valuation grade for Cumberland Pharmaceuticals, Inc. moved from expensive to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 3.04 and an EV to EBITDA ratio of 34.34, which suggests a high valuation relative to earnings before interest, taxes, depreciation, and amortization. Additionally, the ROCE stands at -19.13%, reflecting significant inefficiencies in generating returns on capital employed.\n\nIn comparison to its peers, Cumberland's valuation ratios are concerning; for instance, Regulus Therapeutics, Inc. has a lower EV to EBITDA of -9.1364, indicating a more favorable valuation relative to earnings. Furthermore, while Cumberland has shown impressive returns over the past year at 164.80%, this is contrasted by a lackluster 5-year return of -0.60%, sug..."
      }
    ],
    "total": 7,
    "sid": "1152892",
    "stock_news_url": "https://www.marketsmojo.com/news/cumberland-pharmaceuticals-inc-1152892"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Cumberland Pharmaceuticals, Inc. technically bullish or bearish?

2025-09-20 19:33:06

As of 20 August 2025, the technical trend for Cumberland Pharmaceuticals, Inc. has changed from mildly bullish to mildly bearish. The weekly MACD and KST are both bearish, while the monthly MACD and KST are bullish, indicating mixed signals across time frames. The daily moving averages are bearish, and the weekly Bollinger Bands are also bearish, contributing to the overall bearish stance. The Dow Theory shows a mildly bearish trend on the weekly chart with no trend on the monthly chart. In terms of performance, the stock has outperformed the S&P 500 over the past year with a return of 164.80% compared to the S&P 500's 17.14%, but it has underperformed over the last 3 years and 5 years. Overall, the current technical stance is mildly bearish, reflecting short-term weakness despite strong long-term performance....

Is Cumberland Pharmaceuticals, Inc. overvalued or undervalued?

2025-09-20 18:08:46

As of 2 August 2016, the valuation grade for Cumberland Pharmaceuticals, Inc. moved from expensive to risky, indicating a shift in perception regarding its financial health. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 3.04 and an EV to EBITDA ratio of 34.34, which suggests a high valuation relative to earnings before interest, taxes, depreciation, and amortization. Additionally, the ROCE stands at -19.13%, reflecting significant inefficiencies in generating returns on capital employed. In comparison to its peers, Cumberland's valuation ratios are concerning; for instance, Regulus Therapeutics, Inc. has a lower EV to EBITDA of -9.1364, indicating a more favorable valuation relative to earnings. Furthermore, while Cumberland has shown impressive returns over the past year at 164.80%, this is contrasted by a lackluster 5-year return of -0.60%, sug...

View All News